Post Traumatic Stress Disorder (PTSD) Market Insights, Epidemiology and Market Forecast till 2023
Post-Traumatic Stress Disorder (PTSD) Market Insights, Epidemiology and Market Forecast 2023 Report will provide an overview of the disease and global market size of the Post-Traumatic Stress Disorder (PTSD) with historical and foretasted epidemiological data for the prevalent cases of Post-Traumatic Stress Disorder (PTSD) from 2013 to 2023.
October 5, 2017 /MarketersMedia/ —
Diligent Market is a Business Consultant company and serve as a Knowledge partner across the value chain of Pharmaceutical Industry. With the use of proprietary databases and analytical models, Diligent Market provides cutting-edge data on Post-Traumatic Stress Disorder (PTSD) market and pipeline analysis and API intelligence, helping clients to quantify Post-Traumatic Stress Disorder (PTSD) market events and evaluate their impact on the valuation of its products, portfolios and companies.
Post-Traumatic Stress Disorder (PTSD) is a disorder that develops in some people who have experienced a shocking, scary, or dangerous event or had experience of sudden death of loved one. Most of the people recover from trauma yet there are some who continue to experience problems. People who have PTSD may feel stressed or frightened even when they are not in danger. To be diagnosed with PTSD, an adult must have all of the following for at least 1 month: At least one re-experiencing symptom, At least one avoidance symptom, At least two arousal and reactivity symptoms and at least two cognition and mood symptoms.
The estimated lifetime prevalence of PTSD among adult Americans is 7.8%, with women (10.4%) twice as likely as men (5%) to have PTSD at some point in their lives. This represents a small portion of those who have experienced at least one traumatic event; 60.7% of men and 51.2% of women reported at least one traumatic event. A household survey of UK adults estimated a PTSD prevalence of 2.6% in men and 3.3% in women.
“Post-Traumatic Stress Disorder (PTSD) Epidemiology Insights, 2023” report provides historical as well as forecasted epidemiology of Post-Traumatic Stress Disorder (PTSD) in the 7MM. Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Table of Content of the report –
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM.
3. Executive Summary – Key Findings.
4. Post-Traumatic Stress Disorder (PTSD) Overview – Post-Traumatic Stress Disorder (PTSD) Definition, Pathophysiology, Symptoms and Etiology.
5. Risk Factors Associated with Post-Traumatic Stress Disorder (PTSD)
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
• Key Findings
• Key Sources used and Forecast Methodology
• Prevalent Cases and Incident Cases-2015-2025
• Prevalent & Incident Cases by Category-2015-2025
• Age-Specific Prevalent/ Incident Cases of Post-Traumatic Stress Disorder (PTSD)
• Sex-Specific Prevalent/Incident Cases of Post-Traumatic Stress Disorder (PTSD)
• Disease Type Specific Prevalent/Incident Cases of Post-Traumatic Stress Disorder (PTSD)
8. Prevalent & Incident Cases by 7 MM-2015-2025 – Post-Traumatic Stress Disorder (PTSD) Epidemiology of United States, UK, Germany, France, Spain, Italy and Japan.
9. Key Takeaways
10. Appendix
11. Report Methodology
12. Consulting Services
13. Disclaimer
14. About Us
Avail complete report of 40 pages @ https://www.diligentmarket.com/post-traumatic-stress-disorder-ptsd-epidemiology-insights-to-2025-15433-p.php
Diligent Market also provides a report on pipeline insights, “Post-Traumatic Stress Disorder (PTSD) -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Post-Traumatic Stress Disorder (PTSD). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Post-Traumatic Stress Disorder (PTSD) by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.
The report provides a snapshot of the pipeline development for the Post-Traumatic Stress Disorder (PTSD). It covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Post-Traumatic Stress Disorder (PTSD). The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information. Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Post-Traumatic Stress Disorder (PTSD) the report also covers the dormant and discontinued pipeline projects related to the Post-Traumatic Stress Disorder (PTSD).
Check complete report @ https://www.diligentmarket.com/post-traumatic-stress-disorder-ptsd-pipeline-insight-2017-14593-p.php with key players like Addex Therapeutics Ltd, Amorsa Therapeutics Inc, Azevan Pharmaceuticals Inc, Bionomics Ltd, Catalyst Pharmaceuticals Inc, Cerecor Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Eli Lilly and Company, Embera NeuroTherapeutics Inc, Immodulon Therapeutics Ltd, Intra-Cellular Therapies Inc, Marinus Pharmaceuticals Inc, Neuralstem Inc, NeuroNascent Inc, and many more mentioned in it.
Diligent Market also provides a complete combination of market insights, epidemiology and market forecast till 2023 in one report. According to Diligent Market, the number of Prevalent PTSD cases in 7 major markets is expected to reach XXXX cases in 2025. Diligent Market estimates higher incident probable cases of PTSD in the United States and European Union (EU5) while Japan has comparatively lower prevalence of PTSD.
Report – “Post-Traumatic Stress Disorder (PTSD)-Market Insights, Epidemiology and Market Forecast-2023” will help in developing business strategies by understanding the trends shaping and driving the Post-Traumatic Stress Disorder (PTSD) market. It helps in organizing sales and marketing efforts by identifying the best opportunities for Post-Traumatic Stress Disorder (PTSD) in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan. It helps in understanding the future market competition of Post-Traumatic Stress Disorder (PTSD) therapies in the 7MM and Insightful review of the key market drivers and barriers. The report provides historical as well as forecasted epidemiology of Post-Traumatic Stress Disorder (PTSD) in the 7MM. Report also gives regulatory scenario in major markets. The Report also covers the detailed historical and forecasted Post-Traumatic Stress Disorder (PTSD) market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
The available estimates of PTSD prevalence so far stems mainly from large-scale epidemiological studies conducted in the USA and is restricted to data on adults. Post-traumatic stress disorder is common. Different types of traumatic events are associated with different PTSD rates.
The estimated lifetime prevalence of PTSD among adult Americans is 7.8%, with women (10.4%) twice as likely as men (5%) to have PTSD at some point in their lives. This represents a small portion of those who have experienced at least one traumatic event; 60.7% of men and 51.2% of women reported at least one traumatic event. A household survey of UK adults estimated a PTSD prevalence of 2.6% in men and 3.3% in women.
For complete report with description, table of content and list of figures please contact the Sales Team, Diligent Market at sales@DiligentMarket.com / irfan@DiligentMarket.com or call us at +91 750–707-8687.
Contact Info:
Name: Irfan Tamboli
Organization: Diligent Market
Phone: +91 750–707-8687
For more information, please visit https://www.diligentmarket.com/
Source: MarketersMedia
Release ID: 246267
Copyright © 1999-2013 SproutNews.com
